Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by Sonny7on Oct 06, 2017 12:09am
83 Views
Post# 26784275

Seems Like.....

Seems Like..........the analysts on contract have the same work ethic and level of professional attitude as Shapiro. (If anyone's pays any attention to a dim bulb).  If that's the case I hope it's not for five years. Shapiro enrolled three subjects in the first three years then did nothing that I can see after that.......other than to try to lay claim to the cell pouch and then go over to the ViaCyte camp and create a nasty failure while being paid the big bucks for his "efforts". To announce the end of a seemingly sabotaged contract on a cedar filing is much like saving tissue paper after you blow your nose into it. Senseless. Pointless. Defies any kind of logic. .....Andy has lost his marbles.  

should I be highlighting some some of this?.....what colour?
Bullboard Posts